KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer

Lung carcinoma is still the most common malignancy worldwide. One of the major subtypes of non-small cell lung cancer (NSCLC) is adenocarcinoma (AC). As driver mutations and hence therapies differ in AC subtypes, we theorized that the expression and function of ABC drug transporters important in mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaromi, Luca, Csongei, Veronika, Vesel, Monika, Abdelwahab, ElHusseiny Mohamed Mahmud, Soltani, Amina, Torok, Zsofia, Smuk, Gabor, Sarosi, Veronika, Pongracz, Judit Erzsebet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160643/
https://www.ncbi.nlm.nih.gov/pubmed/34065402
http://dx.doi.org/10.3390/ijms22105384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160643/
https://www.ncbi.nlm.nih.gov/pubmed/34065402
http://dx.doi.org/10.3390/ijms22105384

Ejemplares similares